Evidence map›Paper›PMID 42410832›Full record

ReviewMedicine2026

Comprehensive analysis of factors to consider when using glucocorticoids for sCAP: A review.

Tingrui Zhao, Jing Li, Jing Chen, Jisheng Wang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tingrui ZhaoDepartment of Clinical Pharmacy, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan, People's Republic of China.ORCID 0000-0001-7756-5374
Jing LiDepartment of Neurology, Mianyang people's Hospital, Mianyang, Sichuan, People's Republic of China.
Jing ChenDepartment of Clinical Pharmacy, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan, People's Republic of China.
Jisheng WangDepartment of Clinical Pharmacy, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan, People's Republic of China.ORCID 0009-0003-4482-4220

Funding

Sichuan Provincial Hospital Association Young Pharmacists Research Fund Project YP2202437
6 · The paper itself

Abstract

Severe community-acquired pneumonia (sCAP) is a serious respiratory disease that often requires urgent and comprehensive treatment. The use of glucocorticoids for the treatment of sCAP has been a focus of discussion in the medical community because of their potential benefits and safety concerns. A literature review showed that the benefits of glucocorticoids in the treatment of sCAP may be related to factors such as oxygenation index, high CRP levels, shock, non-influenza, female gender, early application, and hydrocortisone. The application of glucocorticoids in the treatment of sCAP needs to be considered on an individual basis, weighing the potential benefits and risks, and monitoring and preventing possible side effects.

Indexed as

Community-Acquired PneumoniaGlucocorticoidsCommunity-Acquired InfectionsC-Reactive ProteinFemaleHumansHydrocortisoneSex FactorsC-Reactive ProteinGlucocorticoidsHydrocortisonefactorsglucocorticoidshydrocortisonesevere community-acquired pneumonia

Identifiers

PMID42410832
PMCPMC13337090

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.